1299058

Peter C. Boldingh, Pharm.D — FEI 3039281287

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 9, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dilworth, MN (United States)

Additional Details

Clinical BA/BE